AOD-9604 has demonstrated an excellent safety profile in clinical trials involving approximately 900 participants
Serious reactions are uncommon, but anyone with allergies, medication concerns, or underlying medical conditions should discuss them with a medical provider first
if you take 25 micrograms, you absorb 1.6 micrograms
Therefore, any discussion of synergy is largely theoretical and based on extrapolation from individual studies
[18] Lactation studies demonstrate that maternal injections modestly elevate breast-milk B12 concentrations without adverse infant outcomes, supporting compatibility with breastfeeding while underscoring the need for maternal repletion to prevent neonatal deficiency
Food & Drug Administration recently assigned Human GRAS status to AOD 9604, meaning it is listed under the Generally Recognized As Safe (GRAS) program